LakeShore Biopharma Co., Ltd: total_liabilities_and_equity
| Value | {"amount": 190530106, "concept": "us-gaap:LiabilitiesAndStockholdersEquity", "currency": "USD"} |
|---|---|
| Period | (as of 2025-03-31) |
| Status | current |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/568844d1-f28c-48ca-932b-bce935dd3ffb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-069880Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/total-liabilities-and-equity/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/568844d1-f28c-48ca-932b-bce935dd3ffb
History
- supersedes {"unit": "CNY", "value": 1367663211, "concept": "us-gaap:LiabilitiesAndStockholdersEquity"} (evidence 0001213900-25-069880)